(-)-demecolcine increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Demecolcine results in increased expression of TNFRSF9 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TNFRSF9 mRNA CTD PMID:22079256 17beta-estradiol increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Estradiol results in increased expression of TNFRSF9 mRNA CTD PMID:20106945 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of TNFRSF9 mRNA CTD PMID:26496021 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of TNFRSF9 mRNA] and Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of TNFRSF9 protein] CTD PMID:14761676 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TNFRSF9 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Tnfrsf9 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of TNFRSF9 mRNA CTD PMID:21570461 and PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TNFRSF9 mRNA CTD PMID:22298810 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO TNFRSF9 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of TNFRSF9 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of TNFRSF9 mRNA CTD PMID:14761676 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Tnfrsf9 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of TNFRSF9 mRNA CTD PMID:15310856 2,4-diaminotoluene increases expression ISO Tnfrsf9 (Mus musculus) 6480464 2 and 4-diaminotoluene results in increased expression of TNFRSF9 mRNA CTD PMID:20713471 2-tert-butylhydroquinone increases expression ISO TNFRSF9 (Homo sapiens) 6480464 2-tert-butylhydroquinone results in increased expression of TNFRSF9 mRNA CTD PMID:35724838 3,3',4,4',5-pentachlorobiphenyl increases expression ISO TNFRSF9 (Homo sapiens) 6480464 3 more ... CTD PMID:35618242 3,3',5-triiodo-L-thyronine multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 4-OH-2' more ... CTD PMID:14761676 3,3',5-triiodo-L-thyronine increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Triiodothyronine results in increased expression of TNFRSF9 mRNA and Triiodothyronine results in increased expression of TNFRSF9 protein CTD PMID:14761676 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of TNFRSF9 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of TNFRSF9 mRNA CTD PMID:29288687 3-methylcholanthrene increases expression ISO Tnfrsf9 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of TNFRSF9 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol increases expression ISO Tnfrsf9 (Mus musculus) 6480464 bisphenol S results in increased expression of TNFRSF9 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO TNFRSF9 (Homo sapiens) 6480464 bisphenol S results in increased expression of TNFRSF9 mRNA CTD PMID:33312107 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of TNFRSF9 mRNA CTD PMID:24780913 and PMID:25825206 8'-apo-beta,psi-caroten-8'-al increases expression ISO TNFRSF9 (Homo sapiens) 6480464 apocarotenal results in increased expression of TNFRSF9 mRNA CTD PMID:17034753 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of TNFRSF9 mRNA CTD PMID:23630614 more ... aldehydo-D-glucose multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TNFRSF9 mRNA CTD PMID:37567420 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of TNFRSF9 mRNA CTD PMID:20488242 all-trans-retinoic acid increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Tretinoin results in increased expression of TNFRSF9 mRNA CTD PMID:33167477 andrographolide increases expression ISO TNFRSF9 (Homo sapiens) 6480464 andrographolide results in increased expression of TNFRSF9 mRNA CTD PMID:35724838 anthracen-2-amine increases expression EXP 6480464 2-anthramine results in increased expression of TNFRSF9 mRNA CTD PMID:23038007 aripiprazole multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF9 mRNA CTD PMID:31476115 aristolochic acid A increases expression ISO TNFRSF9 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of TNFRSF9 mRNA CTD PMID:33212167 arsenite(3-) affects expression ISO TNFRSF9 (Homo sapiens) 6480464 arsenite affects the expression of TNFRSF9 mRNA CTD PMID:22959463 arsenous acid increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of TNFRSF9 mRNA and Arsenic Trioxide results in increased expression of TNFRSF9 protein CTD PMID:16010437 and PMID:27829220 arsenous acid affects expression ISO TNFRSF9 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of TNFRSF9 mRNA CTD PMID:17530438 Bardoxolone methyl increases expression ISO TNFRSF9 (Homo sapiens) 6480464 bardoxolone methyl results in increased expression of TNFRSF9 mRNA CTD PMID:35724838 benzalkonium chloride increases expression ISO Tnfrsf9 (Mus musculus) 6480464 Benzalkonium Compounds results in increased expression of TNFRSF9 mRNA CTD PMID:30171875 benzo[a]pyrene increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of TNFRSF9 mRNA CTD PMID:19181443 and PMID:32234424 benzo[a]pyrene increases methylation ISO Tnfrsf9 (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of TNFRSF9 intron CTD PMID:27901495 benzo[a]pyrene affects methylation ISO TNFRSF9 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of TNFRSF9 promoter CTD PMID:27901495 benzo[b]fluoranthene decreases expression ISO Tnfrsf9 (Mus musculus) 6480464 benzo(b)fluoranthene results in decreased expression of TNFRSF9 mRNA CTD PMID:26377693 beta-carotene increases expression ISO TNFRSF9 (Homo sapiens) 6480464 beta Carotene results in increased expression of TNFRSF9 mRNA CTD PMID:17034753 beta-naphthoflavone decreases expression ISO TNFRSF9 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of TNFRSF9 mRNA CTD PMID:32858204 bis(2-ethylhexyl) phthalate multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 [Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of TNFRSF9 mRNA CTD PMID:33484791 bisphenol A increases expression ISO Tnfrsf9 (Mus musculus) 6480464 bisphenol A results in increased expression of TNFRSF9 mRNA CTD PMID:26063408 bisphenol A decreases expression ISO Tnfrsf9 (Mus musculus) 6480464 bisphenol A results in decreased expression of TNFRSF9 mRNA CTD PMID:35479511 bisphenol A multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of TNFRSF9 gene CTD PMID:31601247 bisphenol A increases expression ISO TNFRSF9 (Homo sapiens) 6480464 bisphenol A results in increased expression of TNFRSF9 mRNA CTD PMID:33312107 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TNFRSF9 mRNA CTD PMID:30816183 and PMID:32528016 bisphenol A increases methylation ISO Tnfrsf9 (Mus musculus) 6480464 bisphenol A results in increased methylation of TNFRSF9 promoter CTD PMID:27312807 bisphenol A decreases methylation ISO Tnfrsf9 (Mus musculus) 6480464 bisphenol A results in decreased methylation of TNFRSF9 promoter CTD PMID:27312807 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of TNFRSF9 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of TNFRSF9 mRNA CTD PMID:26496021 bisphenol F increases expression ISO TNFRSF9 (Homo sapiens) 6480464 bisphenol F results in increased expression of TNFRSF9 mRNA CTD PMID:33312107 bisphenol F decreases expression ISO TNFRSF9 (Homo sapiens) 6480464 bisphenol F results in decreased expression of TNFRSF9 mRNA CTD PMID:33312107 bortezomib multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased expression of TNFRSF9 mRNA CTD PMID:25522274 butanal increases expression ISO TNFRSF9 (Homo sapiens) 6480464 butyraldehyde results in increased expression of TNFRSF9 mRNA CTD PMID:26079696 calciol increases expression ISO Tnfrsf9 (Mus musculus) 6480464 Cholecalciferol results in increased expression of TNFRSF9 mRNA CTD PMID:17170073 cannabidiol multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of TNFRSF9 mRNA] CTD PMID:27256343 carbon nanotube affects expression ISO Tnfrsf9 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of TNFRSF9 mRNA CTD PMID:23845593 carbon nanotube increases expression ISO Tnfrsf9 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to TNFRSF9 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of TNFRSF9 mRNA more ... CTD PMID:33819548 cisplatin multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Cisplatin co-treated with CDKN1A protein] results in increased expression of TNFRSF9 mRNA and [Cisplatin co-treated with jinfukang] results in decreased expression of TNFRSF9 mRNA CTD PMID:18483502 and PMID:27392435 cisplatin increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Cisplatin results in increased expression of TNFRSF9 mRNA CTD PMID:18483502 cobalt dichloride increases expression ISO TNFRSF9 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of TNFRSF9 mRNA CTD PMID:17553155 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of TNFRSF9 mRNA CTD PMID:24386269 cobalt dichloride decreases expression ISO TNFRSF9 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of TNFRSF9 mRNA CTD PMID:17553155 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of TNFRSF9 mRNA CTD PMID:26033743 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of TNFRSF9 mRNA CTD PMID:26033743 coumarin decreases expression EXP 6480464 coumarin results in decreased expression of TNFRSF9 mRNA CTD PMID:18480146 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of TNFRSF9 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Cyclosporine results in increased expression of TNFRSF9 mRNA CTD PMID:20106945 more ... D-glucose multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TNFRSF9 mRNA CTD PMID:37567420 deoxycholic acid multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of TNFRSF9 mRNA more ... CTD PMID:33819548 dexamethasone multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of TNFRSF9 mRNA CTD PMID:29288687 diarsenic trioxide increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of TNFRSF9 mRNA and Arsenic Trioxide results in increased expression of TNFRSF9 protein CTD PMID:16010437 and PMID:27829220 diarsenic trioxide affects expression ISO TNFRSF9 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of TNFRSF9 mRNA CTD PMID:17530438 diethylstilbestrol increases expression ISO Tnfrsf9 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of TNFRSF9 mRNA CTD PMID:16510352 disodium selenite decreases expression ISO TNFRSF9 (Homo sapiens) 6480464 Sodium Selenite results in decreased expression of TNFRSF9 mRNA CTD PMID:18175754 doxorubicin decreases expression ISO TNFRSF9 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of TNFRSF9 mRNA CTD PMID:29803840 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of TNFRSF9 mRNA CTD PMID:29391264 epichlorohydrin increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Epichlorohydrin results in increased expression of TNFRSF9 mRNA CTD PMID:22723965 ethanol multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 Ethanol promotes the reaction [FOXO3 protein results in increased expression of TNFRSF9 mRNA] CTD PMID:26470730 folic acid multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Folic Acid affects the susceptibility to Pemetrexed] which affects the expression of TNFRSF9 mRNA and [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of TNFRSF9 mRNA CTD PMID:22975265 and PMID:24657277 formaldehyde increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Formaldehyde results in increased expression of TNFRSF9 mRNA CTD PMID:23649840 fructose multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TNFRSF9 mRNA CTD PMID:37567420 fulvestrant multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of TNFRSF9 gene CTD PMID:31601247 furosemide affects expression EXP 6480464 Furosemide affects the expression of TNFRSF9 mRNA CTD PMID:17497460 Geniposide decreases expression ISO Tnfrsf9 (Mus musculus) 6480464 geniposide results in decreased expression of TNFRSF9 mRNA CTD PMID:34718029 genistein increases expression ISO Tnfrsf9 (Mus musculus) 6480464 Genistein results in increased expression of TNFRSF9 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of TNFRSF9 mRNA CTD PMID:22061828 and PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of TNFRSF9 mRNA CTD PMID:24136188 glucose multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TNFRSF9 mRNA CTD PMID:37567420 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of TNFRSF9 mRNA CTD PMID:24915197 glycochenodeoxycholic acid multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of TNFRSF9 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of TNFRSF9 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of TNFRSF9 mRNA more ... CTD PMID:33819548 GW 4064 increases expression ISO Tnfrsf9 (Mus musculus) 6480464 GW 4064 results in increased expression of TNFRSF9 mRNA CTD PMID:26655953 hexadecanoic acid increases expression ISO Tnfrsf9 (Mus musculus) 6480464 Palmitic Acid results in increased expression of TNFRSF9 mRNA CTD PMID:25614714 hexadecanoic acid multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 Quercetin inhibits the reaction [Palmitic Acid results in increased expression of TNFRSF9 mRNA] CTD PMID:25614714 hydroquinone increases expression ISO TNFRSF9 (Homo sapiens) 6480464 hydroquinone results in increased expression of TNFRSF9 mRNA CTD PMID:22723965 ketoconazole decreases expression EXP 6480464 Ketoconazole results in decreased expression of TNFRSF9 mRNA CTD PMID:36653537 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of TNFRSF9 mRNA CTD PMID:24136188 Licarin A multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of TNFRSF9 mRNA CTD PMID:29288687 lipopolysaccharide increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of TNFRSF9 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of TNFRSF9 mRNA CTD PMID:28801915 metformin multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of TNFRSF9 mRNA CTD PMID:29309887 methotrexate decreases expression ISO TNFRSF9 (Homo sapiens) 6480464 Methotrexate results in decreased expression of TNFRSF9 mRNA CTD PMID:17400583 methotrexate increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Methotrexate results in increased expression of TNFRSF9 mRNA CTD PMID:18483502 and PMID:24657277 methotrexate multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of TNFRSF9 mRNA and [Methotrexate co-treated with CDKN1A protein] results in increased expression of TNFRSF9 mRNA CTD PMID:18483502 and PMID:24657277 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of TNFRSF9 mRNA CTD PMID:21515302 N-Nitrosopyrrolidine increases expression ISO TNFRSF9 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in increased expression of TNFRSF9 mRNA CTD PMID:32234424 O-methyleugenol increases expression ISO TNFRSF9 (Homo sapiens) 6480464 methyleugenol results in increased expression of TNFRSF9 mRNA CTD PMID:32234424 ozone multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF9 mRNA CTD PMID:31476115 ozone multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TNFRSF9 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TNFRSF9 mRNA CTD PMID:27106289 and PMID:34911549 ozone increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Ozone results in increased expression of TNFRSF9 mRNA CTD PMID:31476115 p-menthan-3-ol increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Menthol results in increased expression of TNFRSF9 mRNA CTD PMID:26760959 paclitaxel multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of TNFRSF9 mRNA CTD PMID:29309887 paracetamol affects expression ISO Tnfrsf9 (Mus musculus) 6480464 Acetaminophen affects the expression of TNFRSF9 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of TNFRSF9 mRNA CTD PMID:33819548 paracetamol increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Acetaminophen results in increased expression of TNFRSF9 mRNA CTD PMID:29067470 paraquat increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Paraquat results in increased expression of TNFRSF9 mRNA CTD PMID:18836921 paraquat increases expression EXP 6480464 Paraquat results in increased expression of TNFRSF9 mRNA CTD PMID:32680482 PCB138 multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 pemetrexed multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Folic Acid affects the susceptibility to Pemetrexed] which affects the expression of TNFRSF9 mRNA CTD PMID:22975265 pentanal increases expression ISO TNFRSF9 (Homo sapiens) 6480464 pentanal results in increased expression of TNFRSF9 mRNA CTD PMID:26079696 perfluorononanoic acid increases expression ISO TNFRSF9 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in increased expression of TNFRSF9 mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression ISO TNFRSF9 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of TNFRSF9 mRNA CTD PMID:36326898 phorbol 13-acetate 12-myristate multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TNFRSF9 mRNA CTD PMID:16979875 potassium chromate multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TNFRSF9 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO TNFRSF9 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of TNFRSF9 mRNA CTD PMID:22079256 propanal increases expression ISO TNFRSF9 (Homo sapiens) 6480464 propionaldehyde results in increased expression of TNFRSF9 mRNA CTD PMID:26079696 quercetin multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 Quercetin inhibits the reaction [Dietary Fats results in increased expression of TNFRSF9 mRNA] and Quercetin inhibits the reaction [Palmitic Acid results in increased expression of TNFRSF9 mRNA] CTD PMID:25614714 resveratrol increases expression ISO Tnfrsf9 (Mus musculus) 6480464 resveratrol results in increased expression of TNFRSF9 mRNA CTD PMID:25761413 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 sarin increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Sarin results in increased expression of TNFRSF9 mRNA CTD PMID:19522546 serpentine asbestos increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Asbestos and Serpentine results in increased expression of TNFRSF9 mRNA CTD PMID:24160326 serpentine asbestos increases expression ISO Tnfrsf9 (Mus musculus) 6480464 Asbestos and Serpentine results in increased expression of TNFRSF9 mRNA CTD PMID:23917077 silicon dioxide increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of TNFRSF9 mRNA and Silicon Dioxide results in increased expression of TNFRSF9 mRNA CTD PMID:23806026 more ... silicon dioxide increases expression ISO Tnfrsf9 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of TNFRSF9 mRNA CTD PMID:29341224 and PMID:36403901 Soman increases expression EXP 6480464 Soman results in increased expression of TNFRSF9 mRNA CTD PMID:19281266 streptozocin multiple interactions ISO Tnfrsf9 (Mus musculus) 6480464 [Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of TNFRSF9 mRNA CTD PMID:33484791 styrene oxide increases expression ISO TNFRSF9 (Homo sapiens) 6480464 styrene oxide results in increased expression of TNFRSF9 mRNA CTD PMID:22723965 sulforaphane increases expression ISO TNFRSF9 (Homo sapiens) 6480464 sulforaphane results in increased expression of TNFRSF9 mRNA CTD PMID:35724838 Sunset Yellow FCF multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of TNFRSF9 mRNA CTD PMID:33819548 tartrazine multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFRSF9 mRNA CTD PMID:33819548 temozolomide decreases expression ISO TNFRSF9 (Homo sapiens) 6480464 Temozolomide results in decreased expression of TNFRSF9 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO Tnfrsf9 (Mus musculus) 6480464 tert-Butylhydroperoxide results in increased expression of TNFRSF9 mRNA CTD PMID:15003993 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of TNFRSF9 mRNA CTD PMID:21515302 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of TNFRSF9 mRNA CTD PMID:31150632 titanium dioxide increases expression ISO Tnfrsf9 (Mus musculus) 6480464 titanium dioxide results in increased expression of TNFRSF9 mRNA CTD PMID:23557971 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of TNFRSF9 mRNA CTD PMID:30012374 titanium dioxide decreases expression ISO Tnfrsf9 (Mus musculus) 6480464 titanium dioxide results in decreased expression of TNFRSF9 mRNA CTD PMID:29264374 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of TNFRSF9 mRNA CTD PMID:31129395 Tributyltin oxide increases expression ISO Tnfrsf9 (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in increased expression of TNFRSF9 mRNA CTD PMID:22434021 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of TNFRSF9 mRNA CTD PMID:33387578 triclosan multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in increased expression of TNFRSF9 mRNA CTD PMID:33819548 triclosan increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Triclosan results in increased expression of TNFRSF9 mRNA CTD PMID:34681664 trimellitic anhydride increases expression ISO Tnfrsf9 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of TNFRSF9 mRNA CTD PMID:19042947 triptonide increases expression ISO Tnfrsf9 (Mus musculus) 6480464 triptonide results in increased expression of TNFRSF9 mRNA CTD PMID:33045310 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of TNFRSF9 mRNA CTD PMID:21515302 trovafloxacin decreases expression ISO Tnfrsf9 (Mus musculus) 6480464 trovafloxacin results in decreased expression of TNFRSF9 mRNA CTD PMID:35537566 uranium atom affects expression ISO TNFRSF9 (Homo sapiens) 6480464 Uranium affects the expression of TNFRSF9 mRNA CTD PMID:15672453 vincristine increases expression ISO TNFRSF9 (Homo sapiens) 6480464 Vincristine results in increased expression of TNFRSF9 mRNA CTD PMID:23649840 zinc atom affects expression ISO TNFRSF9 (Homo sapiens) 6480464 Zinc affects the expression of TNFRSF9 mRNA CTD PMID:16979875 zinc atom multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of TNFRSF9 mRNA and [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TNFRSF9 mRNA CTD PMID:16979875 and PMID:18593933 zinc(0) affects expression ISO TNFRSF9 (Homo sapiens) 6480464 Zinc affects the expression of TNFRSF9 mRNA CTD PMID:16979875 zinc(0) multiple interactions ISO TNFRSF9 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of TNFRSF9 mRNA and [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TNFRSF9 mRNA CTD PMID:16979875 and PMID:18593933 zoledronic acid decreases expression ISO TNFRSF9 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of TNFRSF9 mRNA CTD PMID:19036117 zoledronic acid increases expression ISO TNFRSF9 (Homo sapiens) 6480464 zoledronic acid results in increased expression of TNFRSF9 mRNA CTD PMID:24714768